Published in Circulation on August 01, 1982
Pericardial fat is associated with prevalent atrial fibrillation: the Framingham Heart Study. Circ Arrhythm Electrophysiol (2010) 1.70
Cor triatriatum and lipomatous hypertrophy of the interatrial septum in the elderly: a case report. Cardiovasc Ultrasound (2010) 0.88
Lipomatous hypertrophy of the interatrial septum: an unusual intraoperative finding. Br Heart J (1991) 0.84
Benign cardiac tumor in a patient with lung malignancy. Clin Res Cardiol (2007) 0.83
Lipomatous hypertrophy of the interatrial septum. Int J Cardiovasc Imaging (2005) 0.79
Interatrial septal thickness as a marker of structural and functional remodeling of the left atrium in patients with atrial fibrillation. Korean J Intern Med (2015) 0.75
Lipomatous hypertrophy of interatrial septum. BMJ Case Rep (2012) 0.75
Excessive interatrial adiposity is associated with left atrial remodeling, augmented contractile performance in asymptomatic population. Echo Res Pract (2016) 0.75
71-year-old woman with dizziness and lipomatous hypertrophy of the left atrium. BMJ Case Rep (2009) 0.75
Isolation of putative progenitor endothelial cells for angiogenesis. Science (1997) 30.27
Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res (1999) 11.32
Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med (1999) 10.16
VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J (1999) 6.62
Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci U S A (2000) 6.59
Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J Clin Invest (1998) 5.95
Mouse model of angiogenesis. Am J Pathol (1998) 4.28
Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation (2001) 4.17
Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. Circulation (1998) 4.10
The morphogen Sonic hedgehog is an indirect angiogenic agent upregulating two families of angiogenic growth factors. Nat Med (2001) 3.85
Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization. Circ Res (1998) 3.79
Age-dependent impairment of angiogenesis. Circulation (1999) 3.47
Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model. J Clin Invest (1994) 3.11
Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia. Circulation (1999) 2.92
A bifunctional gene product involved in two phases of the yeast cell cycle. Nature (1982) 2.90
Regulation of cell size in the yeast Saccharomyces cerevisiae. J Bacteriol (1979) 2.90
Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF. Am J Pathol (1999) 2.83
Direct intramuscular gene transfer of naked DNA encoding vascular endothelial growth factor augments collateral development and tissue perfusion. Circulation (1996) 2.79
Reciprocal relation between VEGF and NO in the regulation of endothelial integrity. Nat Med (1997) 2.73
Genes which control cell proliferation in the yeast Saccharomyces cerevisiae. Nature (1980) 2.45
Perspectives on massive osteolysis. Report of a case and review of the literature. Oral Surg Oral Med Oral Pathol (1983) 2.36
Use of yeast populations fractionated by zonal centrifugation to study the cell cycle. J Bacteriol (1971) 2.35
Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin. Circulation (1998) 2.25
Hypoxia induces vascular endothelial growth factor in cultured human endothelial cells. J Biol Chem (1995) 2.20
Evidence implicating nonmuscle myosin in restenosis. Use of in situ hybridization to analyze human vascular lesions obtained by directional atherectomy. Circulation (1992) 2.20
HMG-CoA reductase inhibitor mobilizes bone marrow--derived endothelial progenitor cells. J Clin Invest (2001) 2.20
Acute cardiac events temporally related to cocaine abuse. N Engl J Med (1986) 2.18
Favorable effect of VEGF gene transfer on ischemic peripheral neuropathy. Nat Med (2000) 2.13
Left ventricular electromechanical mapping to assess efficacy of phVEGF(165) gene transfer for therapeutic angiogenesis in chronic myocardial ischemia. Circulation (2000) 2.12
Chemotactic properties of angiopoietin-1 and -2, ligands for the endothelial-specific receptor tyrosine kinase Tie2. J Biol Chem (1998) 2.12
Indirect angiogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cells, whereas hypoxia upregulates VEGF expression only. Circulation (1994) 2.08
Local delivery of vascular endothelial growth factor accelerates reendothelialization and attenuates intimal hyperplasia in balloon-injured rat carotid artery. Circulation (1995) 2.07
Effect of intracoronary recombinant human vascular endothelial growth factor on myocardial perfusion: evidence for a dose-dependent effect. Circulation (2000) 2.05
Vascular endothelial growth factor(165) gene transfer augments circulating endothelial progenitor cells in human subjects. Circ Res (2000) 2.04
Our national obsession with potassium. Am J Med (1982) 2.02
Multicenter trial of the wallstent in the iliac and femoral arteries. J Vasc Interv Radiol (1997) 1.98
Coronary artery narrowing in coronary heart disease: comparison of cineangiographic and necropsy findings. Ann Intern Med (1979) 1.96
Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo. Circulation (1995) 1.92
Identification of 92-kD gelatinase in human coronary atherosclerotic lesions. Association of active enzyme synthesis with unstable angina. Circulation (1995) 1.90
Expression of transforming growth factor-beta 1 is increased in human vascular restenosis lesions. J Clin Invest (1992) 1.82
Hypoxia-induced paracrine regulation of vascular endothelial growth factor receptor expression. J Clin Invest (1996) 1.82
Normal chest roentgenograms in chronic diffuse infiltrative lung disease. N Engl J Med (1978) 1.78
Estrogen and angiogenesis: A review. Arterioscler Thromb Vasc Biol (2001) 1.76
Cell cycle analysis. Methods Cell Biol (1975) 1.76
Genetic control of cell division in yeast cultured at different growth rates. Nature (1977) 1.75
Reversal of experimental diabetic neuropathy by VEGF gene transfer. J Clin Invest (2001) 1.73
Age-dependent defect in vascular endothelial growth factor expression is associated with reduced hypoxia-inducible factor 1 activity. J Biol Chem (2000) 1.71
Variable expression of the estrogen receptor in normal and atherosclerotic coronary arteries of premenopausal women. Circulation (1994) 1.70
Angiogenesis is induced in a rabbit model of hindlimb ischemia by naked DNA encoding an HIF-1alpha/VP16 hybrid transcription factor. Circulation (2000) 1.70
Antibody blockade of thrombospondin accelerates reendothelialization and reduces neointima formation in balloon-injured rat carotid artery. Circulation (1999) 1.69
Vascular endothelial growth factor/vascular permeability factor produces nitric oxide-dependent hypotension. Evidence for a maintenance role in quiescent adult endothelium. Arterioscler Thromb Vasc Biol (1997) 1.67
Challenges in the manipulation, assessment and interpretation of craving relevant variables. Addiction (2000) 1.66
Vascular endothelial growth factor/vascular permeability factor augments nitric oxide release from quiescent rabbit and human vascular endothelium. Circulation (1997) 1.66
Impaired collateral vessel development associated with reduced expression of vascular endothelial growth factor in ApoE-/- mice. Circulation (1999) 1.66
Potentiated angiogenic effect of scatter factor/hepatocyte growth factor via induction of vascular endothelial growth factor: the case for paracrine amplification of angiogenesis. Circulation (1998) 1.65
p21CIP1-mediated inhibition of cell proliferation by overexpression of the gax homeodomain gene. Genes Dev (1997) 1.63
Can clinical pharmacists affect SF-36 scores in veterans at high risk for medication-related problems? Med Care (2001) 1.61
Stent endothelialization. Time course, impact of local catheter delivery, feasibility of recombinant protein administration, and response to cytokine expedition. Circulation (1997) 1.61
Vascular endothelial growth factor-C (VEGF-C/VEGF-2) promotes angiogenesis in the setting of tissue ischemia. Am J Pathol (1998) 1.61
Evaluation of the effects of intramyocardial injection of DNA expressing vascular endothelial growth factor (VEGF) in a myocardial infarction model in the rat--angiogenesis and angioma formation. J Am Coll Cardiol (2000) 1.58
Gene transfer of naked DNA encoding for three isoforms of vascular endothelial growth factor stimulates collateral development in vivo. Lab Invest (1996) 1.57
Tissue inhibition of angiotensin-converting enzyme activity stimulates angiogenesis in vivo. Circulation (1999) 1.57
Role of endothelial nitric oxide synthase in endothelial cell migration. Arterioscler Thromb Vasc Biol (1999) 1.56
Recovery of disturbed endothelium-dependent flow in the collateral-perfused rabbit ischemic hindlimb after administration of vascular endothelial growth factor. Circulation (1995) 1.51
Three-dimensional reconstruction of human coronary and peripheral arteries from images recorded during two-dimensional intravascular ultrasound examination. Circulation (1991) 1.50
Mibefradil: a new class of calcium-channel antagonists. Ann Pharmacother (1998) 1.48
A new balloon-expandable tantalum coil stent: angiographic patency and histologic findings in an atherogenic swine model. J Am Coll Cardiol (1992) 1.48
The relationship between cell size and cell division in the yeast Saccharomyces cerevisiae. Exp Cell Res (1978) 1.44
Therapeutic angiogenesis for ischemic cardiovascular disease. J Mol Cell Cardiol (2001) 1.43
In vitro evidence that myocardial ischemia resulting from 5-fluorouracil chemotherapy is due to protein kinase C-mediated vasoconstriction of vascular smooth muscle. Cancer Res (1993) 1.43
Effect of a rapid diagnostic method on prescribing patterns and ordering of throat cultures for streptococcal pharyngitis. J Fam Pract (1986) 1.39
Is craving the source of compulsive drug use? J Psychopharmacol (1998) 1.39
Direct intramuscular injection of plasmid DNA encoding angiopoietin-1 but not angiopoietin-2 augments revascularization in the rabbit ischemic hindlimb. Circulation (1998) 1.38
How many of us provide pharmaceutical care? Pharmacotherapy (1997) 1.38
Vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) in normal and atherosclerotic human arteries. Am J Pathol (1997) 1.37
Histopathology of in-stent restenosis in patients with peripheral artery disease. Circulation (1997) 1.36
Focal compensatory enlargement of human arteries in response to progressive atherosclerosis. In vivo documentation using intravascular ultrasound. Circulation (1994) 1.35
Vascular endothelial growth factor inhibits endothelial cell apoptosis induced by tumor necrosis factor-alpha: balance between growth and death signals. J Mol Cell Cardiol (1997) 1.32
Distribution of hyaluronan during extracellular matrix remodeling in human restenotic arteries and balloon-injured rat carotid arteries. Circulation (1996) 1.32
Sudden, unexpected death in avid dieters using the liquid-protein-modified-fast diet. Observations in 17 patients and the role of the prolonged QT interval. Circulation (1979) 1.30
Synthesis of enzymes during the cell cycle. Adv Microb Physiol (1971) 1.29
Anorexia nervosa and sudden death. Ann Intern Med (1985) 1.29
Accelerated restitution of endothelial integrity and endothelium-dependent function after phVEGF165 gene transfer. Circulation (1996) 1.26
VEGF improves myocardial blood flow but produces EDRF-mediated hypotension in porcine hearts. J Surg Res (1996) 1.25
Accuracy of angiographic determination of left main coronary arterial narrowing. Angiographic--histologic correlative analysis in 28 patients. Circulation (1981) 1.25
Klippel-Feil syndrome and deafness. A study with polytomography. Am J Dis Child (1972) 1.24
In vitro analysis of mechanisms of balloon valvuloplasty of stenotic mitral valves. Am J Cardiol (1987) 1.24
The relationship between drug therapy noncompliance and patient characteristics, health-related quality of life, and health care costs. Pharmacotherapy (2000) 1.24
Control of cell division in the yeast Saccharomyces cerevisiae cultured at different growth rates. Exp Cell Res (1978) 1.23
VEGF gene transfer mobilizes endothelial progenitor cells in patients with inoperable coronary disease. Ann Thorac Surg (2000) 1.23
Comprehensive pharmaceutical care in the chain setting. J Am Pharm Assoc (Wash) (1996) 1.22
Sudden unexpected death as a result of anomalous origin of the right coronary artery from the left sinus of Valsalva. Am J Med (1984) 1.22
Physiological assessment of augmented vascularity induced by VEGF in ischemic rabbit hindlimb. Am J Physiol (1994) 1.22
Clinical and economic impact of ambulatory care clinical pharmacists in management of dyslipidemia in older adults: the IMPROVE study. Impact of Managed Pharmaceutical Care on Resource Utilization and Outcomes in Veterans Affairs Medical Centers. Pharmacotherapy (2000) 1.22
Overexpression of p27(Kip1) by doxycycline-regulated adenoviral vectors inhibits endothelial cell proliferation and migration and impairs angiogenesis. FASEB J (2001) 1.21
Intramuscular administration of vascular endothelial growth factor induces dose-dependent collateral artery augmentation in a rabbit model of chronic limb ischemia. Circulation (1994) 1.21
Hypercholesterolemia attenuates angiogenesis but does not preclude augmentation by angiogenic cytokines. Circulation (1997) 1.21
Nitrosoguanidine mutagenesis during nuclear and mitochondrial gene replication. Nature (1974) 1.21